access intranet after hours circle-arrow apply blog caret circle arrow close closer look community outreach community outreach contact contact us down arrow facebook lock solid find a provider find a clinical trial find a provider find a researcher find faculty find-a-service how to apply join leadership left arrow locations logo make a gift map location maximize minimize my chart my chart notification hp notification lp next chevron right nxt prev pay your bill play previous quality and safety refer a patient request a speaker request appointment request an appointment residents corner rss search search jobs Asset 65 submit a story idea symptom checker Arrow Circle Up twitter youtube Dino Logo External Link University Logo Color University Logo Solid Health Logo Solid Arrow Right Circle Book Calendar Date Calendar Search Date Diploma Certificate Dollar Circle Donate Envelope Graduation Cap Map Pin Map Search Phone Pills Podcast

Center Leadership

Don Rockey, M.D.Program Director and Prinical Investigator

Don C. Rockey, M.D.

Dr. Rockey joined MUSC in 2012 as Chair of the Department of Medicine. Previously, he was Division Chief of Liver and Digestive Diseases at UT-Southwestern in Dallas and, prior to that, Director of the multidisciplinary Duke Liver Center. Dr. Rockey is a physician-scientist with NIDDK funding for >25 years, including F32, K08, and R01 support since 1992. His basic research focuses on the liver as a model to study cell and molecular aspects of wound healing, including in vivomodels of liver injury, fibrogenesis and the hepatic wound healing response. Dr. Rockey also focuses on the molecular pathogenesis of portal hypertension, based on the postulate that portal hypertension is not only caused by fibrogenesis in the liver and thus is associated with typical structural changes, but that endothelial dysfunction specifically contributes to the increased intrahepatic resistance typical of most forms of portal hypertension.

Stephen Duncan, DPhil

Associate Director

Stephen A. Duncan, DPhil

Dr. Duncan joined MUSC in 2015 as Chair of the Department of Regenerative Medicine & Cell Biology. His research focuses on the use of mouse models and stem cells to understand the contribution of transcription factors toward embryonic development and diseases of the liver. His laboratory has used knockout mice and mouse embryonic stem cells to garner understanding of molecular pathways that control hepatogenesis and liver function during normal homeostasis as well as liver injury. More recently, Dr. Duncan’s laboratory has been using cells derived from human induced pluripotent stem cells (iPSCs) to study hepatocyte differentiation and to model and potentially treat metabolic liver disease. NIDDK has funded Dr. Duncan’s research continuously for >20 years, he has had leadership roles in several programmatic efforts, and he has published more than 100 original research manuscripts.